SwedenBIO and the EBD Group Collaborate
Tuesday, May 07, 2013
partneringONE® to Facilitate Partnering at Nordic Life Science Days 2013.
Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation
Tuesday, May 07, 2013
Treatment effects of Eliquis® (apixaban) vs. warfarin, across a broad range of warfarin control, are consistent with primary results of ARISTOTLE.
Greenphire Announces New London Office
Tuesday, May 07, 2013
Plans to facilitate expansion in Europe.
MorphoSys Announces Clinical Milestone in Ophthalmology Program
Friday, May 03, 2013
Company has received a milestone payment from Novartis.
Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership
Friday, May 03, 2013
Partners will co-develop a genomic test to help guide treatment decisions for patients diagnosed with leukemia, lymphoma or myeloma.
CROs Offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
Friday, May 03, 2013
Ability to provide complete and cost-effective solutions for pharma and biotechnology firms drives uptake of CRO services.
Zytoprotec Raises EUR 2 Million in Financing from Baxter Ventures
Friday, May 03, 2013
Norbert Riedel will join Zytoprotec’s Supervisory Board.
Plexpress Announces ADME-Tox Programs for CRO’s
Friday, May 03, 2013
EMA and FDA recommend mRNA testing in ADME-Tox studies for superior sensitivity.
Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations
Thursday, May 02, 2013
First-quarter sales of $291.2 million.
|
|
|
|
|
|
